CLINICAL_TRIALS
trial_result
· 2024-06-26
Clinical Trial Update: Safety and Efficacy of Oral Etrasimod in Adult Participants With Moderate-to-Severe Alopecia Areata [Phase 2]
Summary
Phase 2 trial evaluating oral etrasimod for adult moderate-to-severe alopecia areata has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Alopecia Areata | Phase 2 | Status: COMPLETED | Results posted: 2024-06-26